Advanced Cancer clinical trials

Explore recruiting advanced cancer clinical trials.

Recruiting advanced cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1 Study of BMS-986406 as Monotherapy and in Combination in Advanced Tumors

Spain, Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Multicenter Phase 1/2, Open-Label Study of DCC-3014 to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics in Patients with Advanced Tumors and Tenosynovial Giant Cell Tumor

Spain, France, Italy, Poland, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A study to Evaluate AB308 in Combination with AB122 in Participants with Advanced Malignancies (ARC-12)

Spain, Poland

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A First-in-Human Study to Evaluate the Safety and Anti-cancer Activity of the product FS120, which is an Antibody medication, to be administered alone or with Pembrolizumab in Subjects with Advanced Malignancies

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study with ABBV-CLS-484 Alone and in Combination in Subjects with Advanced Tumor Cancer

France, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

An open-label, multi-center, global, rollover study for patients who have previously been treated with capmatinib (INC280) as monotherapy or in combination in a Novartis Sponsored trial

Belgium, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Cancer trials by city

Advanced Cancer in Toronto Advanced Cancer in Vancouver Advanced Cancer in Montreal Advanced Cancer in Calgary Advanced Cancer in Edmonton Advanced Cancer in Ottawa Advanced Cancer in Winnipeg Advanced Cancer in Quebec City Advanced Cancer in Hamilton Advanced Cancer in Kitchener Advanced Cancer in London Advanced Cancer in Halifax Advanced Cancer in New York Advanced Cancer in Los Angeles Advanced Cancer in Chicago Advanced Cancer in Houston

Advanced Cancer clinical trials

Recruiting advanced cancer studies right now

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

Psilocybin Therapy in Advanced Cancer

A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

A Clinical Study of MIL95 in Advanced Malignancies.

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Also recruiting in Europe

A Phase 1 Study of BMS-986406 as Monotherapy and in Combination in Advanced Tumors

A Multicenter Phase 1/2, Open-Label Study of DCC-3014 to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics in Patients with Advanced Tumors and Tenosynovial Giant Cell Tumor

A study to Evaluate AB308 in Combination with AB122 in Participants with Advanced Malignancies (ARC-12)

A First-in-Human Study to Evaluate the Safety and Anti-cancer Activity of the product FS120, which is an Antibody medication, to be administered alone or with Pembrolizumab in Subjects with Advanced Malignancies

A Study with ABBV-CLS-484 Alone and in Combination in Subjects with Advanced Tumor Cancer

An open-label, multi-center, global, rollover study for patients who have previously been treated with capmatinib (INC280) as monotherapy or in combination in a Novartis Sponsored trial

Advanced Cancer trials by city

Other conditions